DocDollars

Ipsen Pharma Sas

France · Reporting entity ID 100000010667

Total reported 2019–2025
$14.6M
#396 of 2,960 reporting companies — 0% of all reported industry payments
$1.42M in general payments across 240 records, plus $13.2M in research funding across 7,172 records.

How it breaks down

General payments $1,422,368
Research funding $13,151,932

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ipsen Pharma Sas reported $14.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #396 of 2,960 reporting companies. 90% of that was research funding and 10% general payments such as consulting, speaking, food and travel. 240 general payment records and 7,172 research records were filed.

Common questions about Ipsen Pharma Sas

How much has Ipsen Pharma Sas paid US doctors?

Ipsen Pharma Sas reported $14,574,300 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,422,368 in general payments, $13,151,932 in research funding.

How does Ipsen Pharma Sas rank among drug and device companies?

It ranks #396 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ipsen Pharma Sas mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.